Crawford Lake Capital Management, LLC Vir Biotechnology, Inc. Transaction History
Crawford Lake Capital Management, LLC
- $0
- Q1 2023
A detailed history of Crawford Lake Capital Management, LLC transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Crawford Lake Capital Management, LLC holds 168,200 shares of VIR stock, worth $1.2 Million. This represents 1.8% of its overall portfolio holdings.
Number of Shares
168,200Holding current value
$1.2 Million% of portfolio
1.8%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding VIR
# of Institutions
219Shares Held
87.4MCall Options Held
127KPut Options Held
1.19M-
Sb Investment Advisers (Uk) LTD London, X016.7MShares$119 Million1.03% of portfolio
-
Black Rock Inc. New York, NY16.4MShares$117 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.1MShares$93.5 Million0.0% of portfolio
-
State Street Corp Boston, MA5.63MShares$40.1 Million0.0% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.57MShares$25.4 Million0.63% of portfolio
About Vir Biotechnology, Inc.
- Ticker VIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 132,638,000
- Market Cap $944M
- Description
- Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...